1.
Müllhaupt B, Semela D, Ruckstuhl L, Magenta L, Clerc O, Torgler R, Negro F, Semmo N. Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland. Swiss Med Wkly [Internet]. 2021 Jan. 19 [cited 2024 Apr. 19];151(0304):w20399. Available from: https://smw.ch/index.php/smw/article/view/2940